Investigation of Chemical Stability and Sterility of Morphine in Intrathecal Pumps for Long-Term Pain Management

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-99
SponsorMeir Medical Center

About this trial

Intrathecal drug delivery systems (IDDS) are effective for managing chronic pain by delivering medications directly into the cerebrospinal fluid. Morphine, a primary opioid used in these systems, must remain chemically stable and sterile over prolonged periods to ensure patient safety and therapeutic efficacy . Previous studies have evaluated morphine stability in vitro under simulated conditions , indicating minimal degradation in saline over time . However, there is limited real-world data regarding the residual morphine in pump reservoirs after extended use . This study seeks to bridge this gap by analyzing morphine aspirated from intrathecal pumps during routine refills in a clinical setting, while comparing it to in vitro samples taken in the clinic .. Objectives Primary Objective: To determine the chemical stability of morphine in intrathecal pump reservoirs over a 3 to 6-month period of clinical use.

Secondary Objective: To assess the sterility of residual morphine and evaluate any microbial contamination.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Receiving intrathecal Morphine (Rafa Laboratories, 20 mg/ml; registration no. 106-25-28981-00).

Scheduled for a routine pump refill procedure at an interval of 3 to 6 months.

Disqualifiers

Evidence of active systemic infection or localized infection at the pump implantation site.

History of recent pump malfunction or refills occurring outside the standard 3 to 6-month window.

Inability to provide informed consent.

Pregnant patients.

Trial population

Adult patients (age ≥ 18 years), Diagnosed with chronic pain and currently treated with an implantable intrathecal pump, receiving intrathecal Morphine (Rafa Laboratories, 20 mg/ml; registration no. 106-25-28981-00), scheduled for a routine pump refill procedure at an interval of 3 to 6 months..

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Culturing and testing chemical stability

    Diagnostic test

    Culturing and testing chemical stability

Treatment groups

5 Participants
are divided into 1 treatment group
Group A: Stability and sterility of intrathecal morphine1 intervention

Trial outcomes

Primary outcomes

1

Rate of positive bacterial culture

Rate of positive bacterial culture from morphine aspirate

Time frame
1 week

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: